2007
DOI: 10.1038/modpathol.3800955
|View full text |Cite
|
Sign up to set email alerts
|

L1 is associated with micrometastatic spread and poor outcome in colorectal cancer

Abstract: L1 is a cell adhesion molecule expressed at the invasive front of colorectal tumors with an important role in metastasis. The aim of the present study was to determine L1 protein expression in a large cohort of colorectal cancer patients and its impact on early metastatic spread and survival. A total of 375 patients that underwent surgical treatment for colorectal cancer were chosen retrospectively. A tissue microarray was constructed of 576 tissue samples from these patients and analyzed by immunohistochemist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
68
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(70 citation statements)
references
References 38 publications
2
68
0
Order By: Relevance
“…However, copy number gain and increased expression of L1 have been demonstrated in breast cancer 36, 7, 8, 9, 10, 11…”
Section: Discussionmentioning
confidence: 99%
“…However, copy number gain and increased expression of L1 have been demonstrated in breast cancer 36, 7, 8, 9, 10, 11…”
Section: Discussionmentioning
confidence: 99%
“…Subsequent work has shown overexpression of L1CAM in a variety of human tumours, in which it is associated with bad prognosis and metastases formation (Thies et al, 2002;Fogel et al, 2003a, b;Boo et al, 2007;Kaifi et al, 2007). Furthermore, L1CAM was detected in tumour-associated endothelium (Issa et al, 2009;Maddaluno et al, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…Expression is often found at the invasive front of primary tumors [24], strongly supporting a role for L1CAM in metastasis. Increased expression of L1CAM has been correlated with lymph node metastases, advanced tumor stage and reduced patient survival [24,25]. In our material CD171 expression was more prominent in borderline and malignant tumors than benign cystadenomas, but it did not relate to tumor grade or stage of the disease.…”
Section: Discussionmentioning
confidence: 61%